Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: A risk factor for cardiac tamponade

Eric R. Silverman, Yan H. Lai, Irene P. Osborn, Francine S. Yudkowitz

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Percutaneous radiofrequency ablation (PRFA) is a minimally invasive procedure used for the treatment of small hepatocellular carcinomas. PRFA is regarded as a much safer alternative to surgical resection or orthotopic liver transplantation. However, serious complications, including cardiac tamponade, have been reported. Two cases of severe cardiac tamponade during PRFA were successfully treated.

Original languageEnglish (US)
Pages (from-to)587-590
Number of pages4
JournalJournal of Clinical Anesthesia
Volume25
Issue number7
DOIs
StatePublished - Nov 2013
Externally publishedYes

Keywords

  • Cardiac tamponade
  • Hepatocellular carcinoma
  • Liver carcinoma
  • Percutaneous radiofrequency ablation
  • Thermoablation

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Fingerprint

Dive into the research topics of 'Percutaneous radiofrequency ablation of hepatocellular lesions in segment II of the liver: A risk factor for cardiac tamponade'. Together they form a unique fingerprint.

Cite this